Exelixis (EXEL) Inventory (2013 - 2026)
Exelixis' (EXEL) quarterly Inventory came in at $26.6 million in Q2 2026, up 7.05% year-on-year from $24.9 million in Q2 2025, and up 22.68% quarter-over-quarter from $21.7 million in Q1 2026.
Exelixis (EXEL) Inventory (2013 - 2026) Analysis & Trends
Exelixis' Inventory history runs 14 years deep, the most recent figure standing at $26.6 million for Q2 2026.
- On a quarterly basis, Inventory rose 7.05% year-over-year to $26.6 million in Q2 2026; TTM through Apr 2026 was $26.6 million, a 7.05% increase from a year earlier, with the FY2026 full-year figure at $21.7 million, down 3.14% from the prior year.
- Inventory climbed to $26.6 million in Q2 2026 per EXEL's latest filing, from $21.7 million in the prior quarter.
- Across five years, Inventory topped out at $33.3 million in Q4 2022 and bottomed at $17.3 million in Q4 2023.
- The 5-year median for Inventory is $25.0 million (2023), against an average of $25.4 million.
- Across the five-year window, Inventory surged 32.18% in 2022 and tumbled 47.98% in 2023, its largest moves.
- Year by year, Inventory stood at $33.3 million in 2022, then tumbled by 47.98% to $17.3 million in 2023, then gained by 21.3% to $21.0 million in 2024, then surged by 30.4% to $27.4 million in 2025, then dropped by 2.91% to $26.6 million in 2026.
- Per Business Quant, the three latest EXEL Inventory figures stand at $26.6 million (Q2 2026), $21.7 million (Q1 2026), and $27.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 26.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 26.61 Mn |
| Jan 2, 2026 | 21.69 Mn |
| Oct 3, 2025 | 27.40 Mn |
| Jul 4, 2025 | 23.48 Mn |
| Apr 4, 2025 | 24.85 Mn |
| Jan 3, 2025 | 22.39 Mn |
| Sep 27, 2024 | 21.01 Mn |
| Jun 28, 2024 | 20.61 Mn |
| Mar 29, 2024 | 21.11 Mn |
| Dec 29, 2023 | 17.32 Mn |
| Sep 29, 2023 | 24.98 Mn |
| Jun 30, 2023 | 28.64 Mn |
| Mar 31, 2023 | 29.91 Mn |
| Dec 30, 2022 | 33.30 Mn |
| Sep 30, 2022 | 26.71 Mn |
| Jul 1, 2022 | 33.02 Mn |
| Apr 1, 2022 | 28.47 Mn |
| Dec 31, 2021 | 27.49 Mn |
| Oct 1, 2021 | 28.24 Mn |
| Jul 2, 2021 | 24.98 Mn |